4.8 Article

Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions

Journal

CIRCULATION
Volume 135, Issue 24, Pages 2336-+

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.116.022069

Keywords

ADAMTS7 protein; coronary artery disease; gene-environment interaction; genome-wide association study; smoking

Funding

  1. National Institutes of Health
  2. Fogarty International
  3. Wellcome Trust
  4. British Heart Foundation
  5. Pfizer
  6. Genentech
  7. Regeneron
  8. Eli Lilly pharmaceuticals
  9. National Institutes of Health [R01-HL-111694, K24-HL-107643]
  10. Wellcome Trust, UK
  11. University of Cambridge from the European Union (EU) [HEALTH-F2-2012-279233]
  12. United Kingdom (UK) Medical Research Council [G0800270]
  13. British Heart Foundation [SP/09/002]
  14. UK National Institute for Health Research Cambridge Biomedical Research Center
  15. European Research Council [268834]
  16. US National Institutes of Health
  17. Merck
  18. Novartis
  19. GlaxoSmithKline
  20. British Heart Foundation [RG/14/5/30893] Funding Source: researchfish
  21. National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish
  22. European Research Council (ERC) [268834] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

BACKGROUND: Common diseases such as coronary heart disease (CHD) are complex in etiology. The interaction of genetic susceptibility with lifestyle factors may play a prominent role. However, gene-lifestyle interactions for CHD have been difficult to identify. Here, we investigate interaction of smoking behavior, a potent lifestyle factor, with genotypes that have been shown to associate with CHD risk. METHODS: We analyzed data on 60 919 CHD cases and 80 243 controls from 29 studies for gene-smoking interactions for genetic variants at 45 loci previously reported to be associated with CHD risk. We also studied 5 loci associated with smoking behavior. Study-specific gene-smoking interaction effects were calculated and pooled using fixed-effects meta-analyses. Interaction analyses were declared to be significant at a P value of < 1.0x10(-3) (Bonferroni correction for 50 tests). RESULTS: We identified novel gene-smoking interaction for a variant upstream of the ADAMTS7 gene. Every T allele of rs7178051 was associated with lower CHD risk by 12% in never-smokers (P= 1.3x10(-16)) in comparison with 5% in ever-smokers (P= 2.5x10(-4)), translating to a 60% loss of CHD protection conferred by this allelic variation in people who smoked tobacco (interaction P value= 8.7x10(-5)). The protective T allele at rs7178051 was also associated with reduced ADAMTS7 expression in human aortic endothelial cells and lymphoblastoid cell lines. Exposure of human coronary artery smooth muscle cells to cigarette smoke extract led to induction of ADAMTS7. CONCLUSIONS: Allelic variation at rs7178051 that associates with reduced ADAMTS7 expression confers stronger CHD protection in never-smokers than in ever-smokers. Increased vascular ADAMTS7 expression may contribute to the loss of CHD protection in smokers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available